"The 70,000 diagnostic codes known as ICD-10 made their long and nervously awaited debut in medical practices today.
Claims for any service performed on October 1 and beyond must bear one or more of the new diagnostic codes â€” more nume"...
For single-dose intraocular use only. Discard unused portion. Intraocular carbachol 0.01% should be used with caution in patients with acute cardiac failure, bronchial asthma, peptic ulcer, hyperthyroidism, G.I. spasm, urinary tract obstruction and Parkinson's disease. The vial stopper contains natural rubber (latex) which may cause severe allergic reactions.
Use only if the container is undamaged.
Studies in animals to evaluate the carcinogenic potential have not been conducted.
Category C. There are no adequate and well-controlled studies in pregnant women. MIOSTAT (carbachol intraocular solution, USP) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
It is not known if this medication is excreted in breast milk. Exercise caution when administering to a nursing woman.
Safety and efficacy in pediatric patients have not been established.
No overall differences in safety or effectiveness have been observed between elderly and younger patients.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 2/4/2016
Additional Miostat Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.